Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Rating) has received an average recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $46.38.
Several analysts have weighed in on RYAN shares. Citigroup started coverage on shares of Ryan Specialty in a research note on Wednesday, December 14th. They set a “neutral” rating and a $42.00 target price for the company. Wells Fargo & Company boosted their price target on shares of Ryan Specialty from $47.00 to $49.00 and gave the company an “overweight” rating in a report on Wednesday, March 1st. UBS Group reduced their price target on shares of Ryan Specialty to $48.00 in a report on Wednesday, November 16th. BMO Capital Markets started coverage on shares of Ryan Specialty in a report on Thursday, January 19th. They set an “outperform” rating and a $51.00 price target for the company. Finally, Barclays reduced their price target on shares of Ryan Specialty to $49.00 in a report on Wednesday, November 16th.
Ryan Specialty Trading Down 3.4 %
Shares of RYAN stock opened at $36.76 on Friday. The stock has a market cap of $9.54 billion, a price-to-earnings ratio of 72.08 and a beta of 0.48. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 2.39. Ryan Specialty has a fifty-two week low of $32.13 and a fifty-two week high of $46.40. The firm’s 50 day moving average price is $42.03 and its two-hundred day moving average price is $41.39.
Insider Transactions at Ryan Specialty
In other news, insider Michael Thomas Vanacker sold 45,000 shares of the stock in a transaction on Monday, March 6th. The stock was sold at an average price of $40.75, for a total transaction of $1,833,750.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 54.30% of the company’s stock.
Hedge Funds Weigh In On Ryan Specialty
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada raised its position in shares of Ryan Specialty by 524.8% during the first quarter. Royal Bank of Canada now owns 781 shares of the company’s stock worth $31,000 after purchasing an additional 656 shares during the period. Arcadia Investment Management Corp MI acquired a new stake in shares of Ryan Specialty during the fourth quarter worth about $34,000. American International Group Inc. acquired a new stake in shares of Ryan Specialty during the second quarter worth about $50,000. Federated Hermes Inc. acquired a new stake in shares of Ryan Specialty during the third quarter worth about $53,000. Finally, Quantbot Technologies LP acquired a new stake in shares of Ryan Specialty during the second quarter worth about $51,000. Institutional investors own 26.82% of the company’s stock.
Ryan Specialty Company Profile
Ryan Specialty Group Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
- Get a free copy of the StockNews.com research report on Ryan Specialty (RYAN)
- What the SVB Financial Collapse Means for U.S. Banks
- MarketBeat Week in Review – 3/6 – 3/10
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.